AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32853042 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral epicondylitis (LE) cohort (women)
Number of subjects: 0
Study 32853042 — intervention group
Group type: EXPERIMENTAL
Intervention: Female patients with lateral epicondylitis (LE)
Number of subjects: 0
Study 33637020 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenvatinib
Number of subjects: 0
Study 33054003 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved methods of physical training with interval cyclic training on treadmills and sensory tracks, therapeutic exercises in the gym (daily, 5 times a week, for a course of 10 procedures)
Number of subjects: 120
Study 33054003 — intervention group
Group type: COMPARATOR
Intervention: Enhanced external counterpulsation, general dry air carbon dioxide, infrared matrix laser therapy
Number of subjects: 120
Study 33054003 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex of physical training and therapeutic procedures for metabolic processes restoration
Number of subjects: 120
Study 33397443 — intervention group
Group type: EXPERIMENTAL
Intervention: LSI + pioglitazone (PGZ) 15 mg qd
Number of subjects: 185
Study 33397443 — intervention group
Group type: COMPARATOR
Intervention: LSI
Number of subjects: 185
Study 35864578 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional 5-fluorouracil/lidocaine/epinephrine (5-FU + LE)
Number of subjects: 45
Study 35864578 — intervention group
Group type: COMPARATOR
Intervention: Cryotherapy
Number of subjects: 45
Study 32410203 — intervention group
Group type: COMPARATOR
Intervention: Kinematic analysis of swallowing mechanics in HNC cohort
Number of subjects: 10
Study 32410203 — intervention group
Group type: COMPARATOR
Intervention: Kinematic analysis of swallowing mechanics in stroke cohort
Number of subjects: 10
Study 32410203 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariate morphometric canonical variate analysis among etiology groups
Number of subjects: 10
Study 35275567 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral truncal tilt training with a wedge
Number of subjects: 33
Study 35275567 — intervention group
Group type: COMPARATOR
Intervention: Control training
Number of subjects: 33
Study 34137226 — intervention group
Group type: EXPERIMENTAL
Intervention: MIA orthodontic system
Number of subjects: 40
Study 34137226 — intervention group
Group type: COMPARATOR
Intervention: Traditional sliding straight wire appliance (control group)
Number of subjects: 40
Study 34116824 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer recovery coach support
Number of subjects: 0
Study 34116824 — intervention group
Group type: COMPARATOR
Intervention: Standard reentry program (Control)
Number of subjects: 0
Study 32140811 — intervention group
Group type: EXPERIMENTAL
Intervention: CP-CEF (four 3-week cycles of carboplatin [CBDCA] and weekly paclitaxel [wPTX] followed by four 3-week cycles of cyclophosphamide, epirubicin, and 5-fluorouracil [CEF])
Number of subjects: 179
Study 32140811 — intervention group
Group type: COMPARATOR
Intervention: P-CEF (four cycles of wPTX followed by four cycles of CEF)
Number of subjects: 179
Study 36339436 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk prediction model based on independent risk factors (HbA1c level, 2hCP, age, FFA)
Number of subjects: 3126
Study 36339436 — intervention group
Group type: EXPERIMENTAL
Intervention: Validation of the risk prediction model
Number of subjects: 3126
Study 32447296 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab (1500 mg IV every 4 weeks for 24 cycles) + concurrent chemoradiotherapy
Number of subjects: 714
Study 32447296 — intervention group
Group type: COMPARATOR
Intervention: Placebo + concurrent chemoradiotherapy
Number of subjects: 714
Study 33413493 — intervention group
Group type: EXPERIMENTAL
Intervention: Coaching for Addiction Recovery Enhancement (CARE)
Number of subjects: 2000
Study 33068342 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture technique of Jingou Diaoyu combined with speech rehabilitation training
Number of subjects: 70
Study 33068342 — intervention group
Group type: COMPARATOR
Intervention: Speech rehabilitation training alone (Control group)
Number of subjects: 70
Study 35177777 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral hydroxyurea 10-20 mg/kg/day
Number of subjects: 60
Study 35177777 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyurea-responders
Number of subjects: 60
Study 35177777 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyurea
Number of subjects: 60
Study 34670666 — intervention group
Group type: EXPERIMENTAL
Intervention: Tormentic acid (TA) at doses of 35, 25, 15 μmol/L
Number of subjects: 0
Study 34670666 — intervention group
Group type: COMPARATOR
Intervention: PDGF-BB (20 ng/mL)
Number of subjects: 0
Study 34670666 — intervention group
Group type: EXPERIMENTAL
Intervention: PDTC (20 ng/mL of PDGF-BB combined with 10 mmol/L of PDTC)
Number of subjects: 0
Study 32925910 — intervention group
Group type: EXPERIMENTAL
Intervention: G6PD deficiency testing
Number of subjects: 1002
Study 32925910 — intervention group
Group type: EXPERIMENTAL
Intervention: G6PD activity measurement
Number of subjects: 1002
Study 32925910 — intervention group
Group type: EXPERIMENTAL
Intervention: Malaria status assessment
Number of subjects: 1002
Study 34591550 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Check-Up (FCU) prevention program
Number of subjects: 2322
Study 32108254 — intervention group
Group type: EXPERIMENTAL
Intervention: Triphasic calcium sulfate/calcium phosphate implant material injection
Number of subjects: 21
Study 32108254 — intervention group
Group type: COMPARATOR
Intervention: Sham group (no implant material injection)
Number of subjects: 21
Study 32108254 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated intact osteoporotic vertebra)
Number of subjects: 21
Study 35197549 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast milk (BM)
Number of subjects: 0
Study 35197549 — intervention group
Group type: COMPARATOR
Intervention: 24% sucrose
Number of subjects: 0
Study 33578837 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurses' knowledge
Number of subjects: 225
Study 33578837 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurses' attitudes
Number of subjects: 225
Study 33578837 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between knowledge and attitudes
Number of subjects: 225
Study 33578837 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge differences based on education level
Number of subjects: 225
Study 33578837 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge differences based on work department
Number of subjects: 225
Study 35363821 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise condition (six weeks of resistance and cardiovascular exercises)
Number of subjects: 15
Study 35363821 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no exercise)
Number of subjects: 15
Study 33468164 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplant (FMT)
Number of subjects: 20
Study 33468164 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 20
Study 32416781 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab plus ipilimumab
Number of subjects: 167
Study 32416781 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab monotherapy
Number of subjects: 167
Study 32416781 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 167
Study 36201851 — intervention group
Group type: EXPERIMENTAL
Intervention: ShipShape enhanced with acceptance and commitment therapy
Number of subjects: 178
Study 36201851 — intervention group
Group type: COMPARATOR
Intervention: ShipShape (in-person)
Number of subjects: 178
Study 34769920 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to multiple types of abuse
Number of subjects: 499
Study 34769920 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to multiple types of abuse during childhood/early adolescence and again in late adolescence
Number of subjects: 499
Study 32384010 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with congenital heart disease (CHD)
Number of subjects: 14433
Study 32384010 — intervention group
Group type: COMPARATOR
Intervention: Reference cohort (matched by sex and birth year)
Number of subjects: 14433
Study 35683447 — intervention group
Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 hydrogel
Number of subjects: 18
Study 33621337 — intervention group
Group type: COMPARATOR
Intervention: Non-targeted ads from the truth antismoking campaign
Number of subjects: 1161
Study 33621337 — intervention group
Group type: EXPERIMENTAL
Intervention: Black-targeted truth ads
Number of subjects: 1161
Study 33621337 — intervention group
Group type: EXPERIMENTAL
Intervention: SGM-targeted truth ads
Number of subjects: 1161
Study 33621337 — intervention group
Group type: COMPARATOR
Intervention: Unrelated control ads
Number of subjects: 1161
Study 34180625 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BTX‐A) injection
Number of subjects: 24
Study 34180625 — intervention group
Group type: COMPARATOR
Intervention: Surgical lip repositioning
Number of subjects: 24
Study 35028656 — intervention group
Group type: EXPERIMENTAL
Intervention: mySmartSkin (MSS)
Number of subjects: 0
Study 35028656 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 33667665 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin alone or in combination with pemetrexed
Number of subjects: 441
Study 33667665 — intervention group
Group type: EXPERIMENTAL
Intervention: ALL dataset
Number of subjects: 441
Study 33667665 — intervention group
Group type: EXPERIMENTAL
Intervention: R1.1 dataset
Number of subjects: 441
Study 33667665 — intervention group
Group type: EXPERIMENTAL
Intervention: Reducing the number of target lesions
Number of subjects: 441
Study 32575868 — intervention group
Group type: EXPERIMENTAL
Intervention: ANFIS model
Number of subjects: 4012
Study 32575868 — intervention group
Group type: EXPERIMENTAL
Intervention: FN model
Number of subjects: 4012
Study 32575868 — intervention group
Group type: EXPERIMENTAL
Intervention: RF model
Number of subjects: 4012
Study 32575868 — intervention group
Group type: EXPERIMENTAL
Intervention: SVM model
Number of subjects: 4012
Study 32575868 — intervention group
Group type: COMPARATOR
Intervention: Empirical correlations
Number of subjects: 4012
Study 35841586 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous (IV) administration of danofloxacin at 10 mg/kg
Number of subjects: 8
Study 35841586 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular (IM) administration of danofloxacin at 10 mg/kg
Number of subjects: 8
Study 35841586 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous (SC) administration of danofloxacin at 10 mg/kg
Number of subjects: 8
Study 35841586 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral (PO) administration of danofloxacin at 10 mg/kg
Number of subjects: 8
Study 34110712 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-high intensity resistance and aerobic exercise intervention (n = 8)
Number of subjects: 14
Study 34110712 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 6)
Number of subjects: 14
Study 34326299 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS
Number of subjects: 57
Study 34326299 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 57
Study 32458074 — intervention group
Group type: EXPERIMENTAL
Intervention: Waist-shaped interdental brush
Number of subjects: 10
Study 32458074 — intervention group
Group type: COMPARATOR
Intervention: Straight interdental brush
Number of subjects: 10
Study 32752228 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief group cognitive behavioral therapy (BG-CBT) - six brief weekly sessions
Number of subjects: 56
Study 32752228 — intervention group
Group type: COMPARATOR
Intervention: Conventional care (control group)
Number of subjects: 56
Study 35572910 — intervention group
Group type: EXPERIMENTAL
Intervention: Early extubation combined with a physical training program
Number of subjects: 96
Study 35572910 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing intervention
Number of subjects: 96
Study 33770739 — intervention group
Group type: EXPERIMENTAL
Intervention: Empathic caring (three face-to-face nursing counseling sessions)
Number of subjects: 62
Study 33770739 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 62
Study 33220462 — intervention group
Group type: EXPERIMENTAL
Intervention: Bencycloquidium bromide (BCQB) 125 μg
Number of subjects: 72
Study 33220462 — intervention group
Group type: EXPERIMENTAL
Intervention: Bencycloquidium bromide (BCQB) 250 μg
Number of subjects: 72
Study 33220462 — intervention group
Group type: EXPERIMENTAL
Intervention: Bencycloquidium bromide (BCQB) 500 μg
Number of subjects: 72
Study 33220462 — intervention group
Group type: EXPERIMENTAL
Intervention: Bencycloquidium bromide (BCQB) 750 μg
Number of subjects: 72
Study 33220462 — intervention group
Group type: EXPERIMENTAL
Intervention: Bencycloquidium bromide (BCQB) 1125 μg
Number of subjects: 72
Study 33220462 — intervention group
Group type: EXPERIMENTAL
Intervention: Bencycloquidium bromide (BCQB) 1500 μg
Number of subjects: 72
Study 33220462 — intervention group
Group type: EXPERIMENTAL
Intervention: Bencycloquidium bromide (BCQB) 2000 μg
Number of subjects: 72
Study 33220462 — intervention group
Group type: EXPERIMENTAL
Intervention: Bencycloquidium bromide (BCQB) 750 μg/d (multiple dose)
Number of subjects: 72
Study 33220462 — intervention group
Group type: EXPERIMENTAL
Intervention: Bencycloquidium bromide (BCQB) 1000 μg/d (multiple dose)
Number of subjects: 72
Study 33220462 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 35501736 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-thioguanine (6TG) at a low dose of 2.5–12.5 mg/m2/day, combined with reduced 6-mercaptopurine (6MP) starting dose of 50 mg/m2/day
Number of subjects: 778
Study 35501736 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate (MTX)/6-mercaptopurine (6MP) maintenance therapy
Number of subjects: 778
Study 32620344 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine combined with orthokeratology (ACO)
Number of subjects: 154
Study 32620344 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthokeratology (OK)
Number of subjects: 154
Study 32620344 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine
Number of subjects: 154
Study 32620344 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo and single vision glasses)
Number of subjects: 154
Study 36261768 — intervention group
Group type: EXPERIMENTAL
Intervention: Group behavioral weight loss intervention with privacy features (present or not), matching participants to group based on weight loss barriers (matched or not), and intervention format (online or in-person)
Number of subjects: 0
Study 36261768 — intervention group
Group type: COMPARATOR
Intervention: Individual format interventions
Number of subjects: 0
Study 34280820 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity aerobic exercise (EX)
Number of subjects: 35
Study 34280820 — intervention group
Group type: COMPARATOR
Intervention: Light-intensity control (CON)
Number of subjects: 35
Study 35619218 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic conditioning (RIC) with cuff pressure of 200 mm Hg, performed twice a day for seven consecutive days
Number of subjects: 558
Study 35619218 — intervention group
Group type: COMPARATOR
Intervention: Sham-RIC with cuff pressure of 60 mm Hg, performed twice a day for seven consecutive days
Number of subjects: 558
Study 35619218 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic conditioning (RIC)
Number of subjects: 558
Study 35619218 — intervention group
Group type: COMPARATOR
Intervention: Sham-RIC
Number of subjects: 558
Study 33676151 — intervention group
Group type: EXPERIMENTAL
Intervention: Balint groups (intervention)
Number of subjects: 311
Study 33676151 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 311
Study 32067512 — intervention group
Group type: COMPARATOR
Intervention: 30 mg/kg deferasirox
Number of subjects: 160
Study 32067512 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg omeprazole and 30 mg/kg deferasirox
Number of subjects: 160
Study 32067512 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg vitamin E and 30 mg/kg deferasirox
Number of subjects: 160
Study 32067512 — intervention group
Group type: EXPERIMENTAL
Intervention: 420 mg silymarin and 30 mg/kg deferasirox
Number of subjects: 160
Study 34230556 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening invitations with imposed deadlines (short deadline with no incentive)
Number of subjects: 7711
Study 34230556 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening invitations with imposed deadlines (small financial incentive)
Number of subjects: 7711
Study 34230556 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening invitations with imposed deadlines (large declining financial incentive)
Number of subjects: 7711
Study 34230556 — intervention group
Group type: COMPARATOR
Intervention: Control group (no deadlines)
Number of subjects: 7711
Study 35821886 — intervention group
Group type: EXPERIMENTAL
Intervention: ADC value of stage IA CC
Number of subjects: 101
Study 35821886 — intervention group
Group type: EXPERIMENTAL
Intervention: ADC value after second chemotherapy in effective patients
Number of subjects: 101
Study 35821886 — intervention group
Group type: EXPERIMENTAL
Intervention: ADC value before treatment and after first chemotherapy in ineffective patients
Number of subjects: 101
Study 35821886 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic performance of ADC value to differentiate CC and normal cervix
Number of subjects: 101
Study 35821886 — intervention group
Group type: EXPERIMENTAL
Intervention: Omics model based on OSag-T2WI&OAx-T2FS
Number of subjects: 101
Study 35821886 — intervention group
Group type: EXPERIMENTAL
Intervention: Group model based on OAx-T1WI
Number of subjects: 101
Study 33507924 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamified interview format
Number of subjects: 1266
Study 33171944 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary diversity intervention (not specified in detail)
Number of subjects: 47
Study 33171944 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional status assessment (anthropometry and biochemical markers)
Number of subjects: 47
Study 33171944 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma zinc concentration measurement
Number of subjects: 47
Study 33171944 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma selenium concentration measurement
Number of subjects: 47
Study 33171944 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron status assessment (serum ferritin and blood hemoglobin)
Number of subjects: 47
Study 34911706 — intervention group
Group type: EXPERIMENTAL
Intervention: risankizumab 150 mg
Number of subjects: 964
Study 34911706 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 964
Study 32179952 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive linear stapler technique for intrathoracic esophagogastrostomy
Number of subjects: 0
Study 32179952 — intervention group
Group type: COMPARATOR
Intervention: Traditional intrathoracic anastomosis
Number of subjects: 0
Study 35125179 — intervention group
Group type: EXPERIMENTAL
Intervention: Ovulation induction/OS with timed intercourse (for polycystic ovary syndrome)
Number of subjects: 1650
Study 35125179 — intervention group
Group type: EXPERIMENTAL
Intervention: Ovulation induction/OS with intrauterine insemination
Number of subjects: 1650
Study 35125179 — intervention group
Group type: EXPERIMENTAL
Intervention: Gonadotropin use
Number of subjects: 1650
Study 35125179 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictive model for clinical pregnancy
Number of subjects: 1650
Study 35125179 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictive model for multiple pregnancy
Number of subjects: 1650
Study 35125179 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors predicting cumulative pregnancy rates
Number of subjects: 1650
Study 32901379 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT) using diode laser (980 nm, 0.3 W) for 10 seconds at six spots along the midpalatal suture during active and passive phases of rapid palatal expansion.
Number of subjects: 34
Study 32901379 — intervention group
Group type: COMPARATOR
Intervention: Control group received sham irradiations with the laser in standby mode.
Number of subjects: 34
Study 35144607 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone aftercare groups for family carers, 6 months duration
Number of subjects: 141
Study 35144607 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone aftercare groups for family carers
Number of subjects: 141
Study 35144607 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 141
Study 34791044 — intervention group
Group type: EXPERIMENTAL
Intervention: Totally extraperitoneal (TEP) repair
Number of subjects: 202
Study 34791044 — intervention group
Group type: COMPARATOR
Intervention: Open anterior repair (modified Lichtenstein)
Number of subjects: 202
Study 35241775 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-day amoxicillin treatment
Number of subjects: 3000
Study 35241775 — intervention group
Group type: COMPARATOR
Intervention: 5-day amoxicillin treatment
Number of subjects: 3000
Study 33423594 — intervention group
Group type: EXPERIMENTAL
Intervention: Football Fitness group (FFG, n = 46)
Number of subjects: 68
Study 33423594 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON, n = 22)
Number of subjects: 68
Study 36158727 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous care model (group consultation sessions, once every week, four sessions each 60‐90 min)
Number of subjects: 110
Study 36158727 — intervention group
Group type: COMPARATOR
Intervention: Normal cares (control group)
Number of subjects: 110
Study 33837481 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxibustion Robot (MR)
Number of subjects: 70
Study 33837481 — intervention group
Group type: COMPARATOR
Intervention: Manual Moxibustion (MM)
Number of subjects: 70
Study 35488826 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipenem/cilastatin/relebactam (IMI/REL)
Number of subjects: 0
Study 35488826 — intervention group
Group type: COMPARATOR
Intervention: Piperacillin-tazobactam (PIP/TAZ)
Number of subjects: 0
Study 35246775 — intervention group
Group type: EXPERIMENTAL
Intervention: Vermont Family Based Approach (VFBA)
Number of subjects: 81
Study 35246775 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 81
Study 33653365 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg/day Vitamin C supplementation
Number of subjects: 24